Medtronic Opens Fiscal Year With Spine Share Gains

Medtronic's logo

Medtronic reported FY 1Q22 orthopedic revenue of $758.1 million, +10.1% vs. FY 1Q21. Strength in biologics, ongoing procedure recovery for core spine and strong capital sales of navigation and imaging drove sales.

Medtronic's spine franchise declined -1.8% compared to the same period in the calendar year 2019, but the company remains...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us